Learn about COSELA: The first and only multilineage myeloprotection therapy for patients receiving chemotherapy for extensive-stage small cell lung cancer.

Learn about the recommended dose of COSELA and how it should be administered as a 30-minute intravenous infusion prior to each chemotherapy admistration.

COSELA is the first and only therapy that provides a novel approach to the clinical challenge of myelosuppression by proactively helping to protect HSPCs, to enable myeloprotection. …

COSELA is used to treat adults taking certain chemotherapies (platinum/etoposide or topotecan) for extensive-stage small cell lung cancer. COSELA is an injection for intravenous (IV) use …

COSELA is a prescription medicine used to help reduce the occurrence of low blood cell counts caused by damage to bone marrow from chemotherapy. COSELA is used to treat adults …

Oct 1, 2021 · COSELA is indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing …

COSELA™ (trilaciclib) is indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing …

See the COSELA pivotal study multilineage data, evaluating neutropenia, anemia, thrombocytopenia, and dose reductions/delays in 1st-line chemotherapy.

COSELA® (trilaciclib) is indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing …

COSELA ® (trilaciclib) can help protect the blood-forming cells and lower your risk of bone marrow suppression, a harmful side effect of chemo. Learn more about how COSELA can …